|
|
 |
Publications
| Publications |
 |
Mor,
G., Saphier, D., & Feldman, S. (1986). Inhibition by corticosterone
of paraventricular nucleus multiple-unit activity responses
to sensory stimuli in freely moving rats. Experimental Neurology,
94(2), 391-399. |
|
Mor,
G., Saphier, D., & Feldman, S. (1987). Neural pathways that
mediate the effects of afferent stimuli on paraventricular nucleus
multiunit activity in freely moving rats. Journal of Neuroscience
Research, 17(4), 452-458. |
|
Saphier,
D., Abramsky, O., Mor, G., & Ovadia, H. (1987). Multiunit
electrical activity in conscious rats during an immune response.
Brain Behavior and Immunity, 1(1), 40-51. |
|
Saphier,
D., Abramsky, O., Mor, G., & Ovadia, H. (1987). A neurophysiological
correlate of an immune response. Annals of the New York Academy
of Sciences, 496(354), 354-9. |
|
Saphier,
D., Mor, G., & Feldman, S. (1988). Neurogenic stimuli alter
preoptic area and amygdala unit activity: central effects of
olfactory projections on paraventricular nucleus units. Experimental
Neurology, 100(1), 71-82. |
|
Mor, G. (1988). Neural Responses to Neurogenic Stimuli: Effects
of Lesions and Glucocorticoids. Thesis. Master of Sciences,
The Hebrew University. |
|
Ovadia,
H., Saphier, D., Mor, G., Maimon, A., & Abramsky, O. (1991).
Changes in brain during an immune response. Journal of Neuroimmunology,
17, 253-263. |
|
Saphier,
D., Mor, G., Ovadia, H., Maimon, A., & Abramsky, O. (1991).
Absence of neural responses following suppression of the immune
response. International Journal of Neuroscience, 56(1-4), 277-282. |
|
Bernard,
G., Mor, G., Amir-ZAltsman, Y., & Kohen, F. (1992). Idiometric
assay, anti-idiotypes and molecular mimicry. Communication
Laboratory and Medicine, 3, 57-62. |
|
Mor,
G., Amir, Z. Y., Barnard, G., & Kohen, F. (1992). Characterization
of an antiidiotypic antibody mimicking the actions of estradiol
and its interaction with estrogen receptor. Endocrinology, 130(6),
3633-40. |
|
Amir-Zaltsman,
Y., Mor, G., Globerson, A., Thole, H., & Kohen, F. (1993). Expression
of Estrogen Receptors in Thymocytes. Endocrine, 1, 211-217. |
|
Ben-Hur,
H., Mor, G., Blickstein, I., Likhman, I., Kohen, F., Dgani,
R., Insler, V., Yaffe, P., & Ornoy, A. (1993). Localization
of estrogen receptors in vertebrae of human fetuses. Calcified
Tissue International, 53, 91-96. |
|
Mor,
G., Amir-Zaltsman, Y., Barnard, G., Ben-Hur, H., & Kohen, F.
(1993). Evidence for the expression of Estrogen Receptors in
Monocytes. Endocrine, 1, 387-395. |
|
Mor, G. (1993). Estrogen and the Immune System: I. Expression
of estrogen receptor in the cells of the immune system; II.
Molecular mimicry. Thesis. Doctor of Philosophy, The Weizmann
Institute of Sciences. |
|
Sömjen,
D., Mor, G., Amir, Z. Y., Jaccard, N., Weizman, Y,. Kaye, AM
, Kohen, F. (1994). Cell specific stimulation of bone-cells
by gonodal-steroids in-vivo and in-vitro. Calcified Tissue International,
54 (4), 342-346. |
|
Ben-Hur,
H., Mor, G., Blickstein, I., Dgani, R., Insler, V., Amir-Zaltsman,
Y., & Kohen, F. (1995). Immunofluorescent assessement of estrogen
receptor distribution in normal and pathological human endometrium.
Acta Obstetricia et Gynecologica Scandinavica . 74: 97-102.
|
|
Ben-Hur,
H., Mor, G., Insler, V., Blickstein, I., Amir-Zaltsman, Y.,
Sharp, A., Globerson, A., & Kohen, F. (1995). Menopause is associated
with a significant decrease in the expression of estrogen receptors
in human peripheral monocytes. American Journal of Reproductive
Immunology. 34: 363-369. |
|
Sömjen,
D., Amir, Z. Y., Mor, G. Jaccard, N., Weizman, Y,. Barnard,
G., & Kohen, F. (1995). Anti-idiotipic antibody as an estrogen
mimetic: Rremoval of the Fc fragment converts agonist to antagonist.
Journal of Endocrinology. 145: 409-416. |
|
Hagiwara
E., Mor, G., Abbasi F., Klinman D. (1995). Phenotype and frequency
of cells secreting IL-2, IL-4, IL-6 , IL-10, INFg and TNFa in
the peripheral Blood. Cytokines. 7: 815-822. |
|
Mor,
G., Klinman, D., Shapiro, S., Hagiwara, E., Sedegha, M., Norman,
J.A., Hoffman, L.S., Steinberg, A. (1995). Complexity of the
cytokine and antibody response elicited by immunizing mice with
PyCSP plasmid DNA. Journal of Immunology. 155: 2039-2046. |
|
Mor,
G., Yamshchikov, G., Sedegah, M., Takeno, M., Wang, R., Hoffman,
S., Klinmann, DM. (1996). Induction of Neonatal Tolerance
by Plasmide DNA Vaccination. Journal of Clinical Investigation.
98 (12): 2700-2705. |
|
Naftolin,
F., Mor, G., Luquin, S., Horvath, T.L., Kohen, F., & Garcia-Segura,
L. (1996). Synaptic remodeling in the arcuate nucleus during
the estrous cycle is induced by estrogen and precedes the midcycle
gonadotrophin surge. Endocrinology. 137: 5576-5580. |
|
Sömjen,
D., Amir, Z. Y., Mor, G., Gayer, B., Lichter, S., Barnard, G.,
& Kohen, F. (1996). Anti-idiotipic antibody as an estrogen mimetic
in vivo: Stimulation of creatine -kinase specific activity in
rat animal models. Journal of Endocrinology. 149: 305-312. |
|
Ben-Hur,
H., Dgani, R., Insler, V., Lifschitz, B., Blickstein, I., Mor,
G., Kohen, F., Shani, A., Biran, H. (1996). Hyperestrogenemia
and presence of estrogen receptors associated with epithelial
ovarian tumor of low malignant potential. European Journal
of Gynecological Oncology. 17(4): 260-263. |
|
Mor,
G., Singla, M., Steinberg, AD., Hoffman, L., Okuda, K., Klinman,
DM. (1997). Do DNA Vaccines Induce Systemic Autoimmunity? Human
Gene Therapy. 8: 293-300. |
|
Dayan,
M., Zinger, H., Kalush, F., Mor, G., Amir, Z. Y., Kohen, F.,
Sthoeger, Z., & Mozes, E. (1997). Tamoxifen and anti-estradiol
antibody treatment have a beneficial effect on experimental
Systemic Lupus Erythematosus and modulate cytokine secretion
to normal levels. Immunology. 90: 101-108. |
|
Sthoege,R
Z., Dayan, M., Zinger, H., Kalush, F., Mor, G., Zaltman, Y.,
Kohen, F., Mozes, E. (1997). Treatments with tamoxifen and an
anti-estradiol antibody have beneficial effects on experimental
SLE via cytokine modulation. Annals of the New York Academy
of Science. 815: 367-368. |
|
Sömjen,
D., Tordjman K., Weizman, A, Mor, G. Amir, Z. Y., Kohen,F.,
Kaye, A.M. (1997). Estrogen stimulation of creatine kinase B
specific activity in 3T3L1 adipocytes after their differentiation
in culture: Dependence on estrogen receptor. Journal of Steroid
Biochemistry and Molecular Biology. 62 (5): 401-408. |
|
Klinman
DM. Takeno M. Ichino M. Gu M. Yamshchikov G. Mor G. Conover
J. (1997) DNA vaccines: safety and efficacy issues. Springier
Seminars in Immunopathology. 19(2): 245-256. |
|
Mor,
G. (1998). Plasmid DNA: A new era in vaccinology. Biochemical
Pharmacology. 55:1151-1153. |
|
Gutierrez,
L., Janzen, A., Mor,G. (1998). Fas Ligand expression in normal,
hyperplastic and neoplastic prostate. Modern Pathology. 78 (1)
601. |
|
Mor,
G., Gutierrez, L.S., Eliza, M., Kahyaogili, F., Arici, A. (1998).
Induction of apoptosis mediated by the Fas-Fas ligand system
in human placental trophoblast and gestational trophoblastic
disease. American Journal of Reproductive Immunology: 40:89-94.
|
|
Kohen,
F., Abel, L., Sharp, A., Amir, Z. Y., Sömjen, D., Luria, S.,
Mor, G., Thole, H., Globerson, A. (1998). Oestrogen receptor
expression in thymocytes as function of age. Developmental Biology.
5: 277-285. |
|
Sömjen,
D., Amir, Z. Y., Mor, G. Gayer, B., Lichter, S,. Nevo, N., &
Kohen, F. (1998). A monoclonal antibody to oestradiol attenuates
the stimulation of the specific activity of the brain type creatine
kinase by estrogen in vivo and in vitro. Journal of Steroid
Biochemistry and Molecular Biology. 64:297-304. |
|
Bechmann,
I., Mor, G., Nilson, J.,Eliza, M., Nisch, R., Naftolin, (1998)
F. FasL (APO-1-L, CD95L) is expressed in the intact human and
rat brain and forms an immunological brain barrier. European
Journal of Neuroscience. 10 (Supp.) :61-61 |
|
Mor,
G., and Eliza M., (1998). Autoimmunity and Tolerance. In: Methods
in Molecular Medicine. Edited by Lowrie, D.B. and Whalen, R.
The Human Press Inc. |
|
Mor,
G., Yue,W., Santen, R.J., Gutierrez, L., Eliza, M., Bernstein,
L., Harada, N., Wang, J., Lysiak, J., Diano, S., Naftolin, F.
(1998). Macrophages, estrogen and the microenviron- ment of
breast cancer. Journal of Steroid Biochemistry and Molecular
Biology: 67: 403-411. |
|
Mor,
G., Naftolin, F. (1998) Estrogen Menopause and the Immune system.
Journal of the British Menopause Society: 4 (1): 4-8
|
|
Nilsen,
J., Mor, G., Naftolin, F. (1998) Raloxifene induces neurite
outgrowth in estrogen receptor positive PC12 cells. Menopause:
5: 211-216 |
|
Diano,
S.; Horvath, T.; Mor, G.; Register, T.; Adams, M.; Harada, N.;
Naftolin, F. (1998) Aromatase and estrogen receptor immunoreactivity
in the coronary arteries of monkeys and humans. Menopause: 6
(1) 21-28 |
|
Ichino,
M., Mor, G., Conover, J., Weiss, WR., Takeno, M., Ishii, KJ.,
Klinman, DM. (1999) Factors associated with the development
of neonatal tolerance after the administration of a plasmid
DNA vaccine. Journal of Immunology. 162: 3814-3818 |
|
Gutierrez,
L., Eliza, M., Niven-Fairchild, T., Mor, G. (1999). Fas/Fas-Ligand
system induced apoptosis in human breast carcinoma: A mechanism
for immune evasion. Breast Cancer Research and Treatment. 54
(3):245-253. |
|
Garcia-Velascol,
J., Arici, A., Naftolin, F., Zreick, T., Mor, G. (1999) Macrophage-derived
growth factors regulate Fas Ligand expression in endometrial
stromal cells. A role in endometriosis. Molecular Human Reproduction.
5:642-650. (Full Text). |
|
Santen,
RJ., Yue, W., Naftolin, F., Mor, G., Bernstein, L., (1999) Potential
role of aromatase overexertion in the genes of breast carcinoma.
Endocrine Related Cancer 6:235-243. |
|
Senturk,
L.M., Seli, E., Gutierrez, L.M., Mor, G., Zeyneloglu, H.B.,
Arici, A. (1999). Monocyte Chemoattractant Protein-1 expression
in human corpus luteum. Molecular Human Reproduction 5:697-702.
(Full Text) |
|
Bechmann,
I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R., Naftolin, F.
(1999). FasL (CD95L) is expressed in normal rat and human brain
and forms an Immunological Brain Barrier (IBB). Glia. 27:62-74
|
|
Mor,
G., Nilson, J., Horvath, T., Bechmann, I., Garcia-Segura, LM.,
Naftolin, F. (1999) Estrogen and microglia: a regulatory system
that affects the brain. Journal of Neurobiology. 40: 484-496
|
|
Ben-Hur, H., Gurevich, P., Berman, V., Tendler, Y., Huszar,
M., Tchanishev, R., Hagay, Z., Ben-Arie, A., Mor, G., Zaltsman,
Y., Kohen, F., Zusman, I. (1999) Apoptosis and apoptosis related
proteins (Fas, FasL, bcl-2, p53) in the epithelium of human
ovarian tumors: Immunohistochemical and morphometric studies.
European Journal of Obstetric Oncology: 20:249-253 |
|
Mor,
G. and Brown WD (1999) Fas and Fas Ligand mediated immune privileged
status of the tumor. In Cancer Immunotherapy Protocols. The
Human Press Inc. |
|
Mor,
G. Menopause, estrogens and the immune system (1999) Boletin
de la Sociedad Chilena de Climaterio 4:14-16 |
|
Silva
I., Rodriguez, MA., Mor, G., Naftolin, F. (2000) Alzheimer's
Disease and Estrogens. Advances in obstetrics and Gynecology.
52:285-293 |
|
Aschkenaszi,
S. and Mor, G. (2000) Sex hormones, the immune system and menopause.
Menopause Management. 9(2):6-13 |
|
Hsu,
CD., Basherram H., Lu, LC., Meaddough, E., Lee, IS., Harirah,
H., Mor, G. (2000) Elevated serum soluble Fas in preeclampsia.
American Journal of Obstetrics and Gynecology. In press
|
|
Yamshchikov,
G.V., Mor, G., Takeno, M., Klinman, D. (2000). DNA immunization:
studies comparing the immunogenicity of several HIV-1-ENV constructs.
AIDS Research and Human Retroviruses. Submitted. |
|
Mor,
G., Kohen, F., Brown, S., Nilsen, J., Brown, W., Naftolin, F.
(2000). Regulation of Fas Ligand expression in breast cancer
cells by estrogen: Functional differences between estradiol
and tamoxifen. Journal of Steroid Biochemistry and Molecular
Biology 72/6 |
|
Ben-Hur,
H., Gurevich, P., Huszar, M., Berman, V., Tendler, Y., Zinder,
O., Tchanishev, R., Gershon, S., Ben-Arie, A., Mor, G., Zaltsman,
Y., Kohen, F., Zusman, I. (2000) Apoptosis and apoptosis-related
proteins in lymphoid elements of human ovarian tumors. European
Journal of Gynecology and Oncology. 21(1):53-7. |
|
Ben-Hur,
H. Gurevich, P. Ben-Arie, A. Huszar, M. Berman, V. Tendler,
Y. Tchanishev, R. Mor, G. Gershon, S. Zusman, I. (2000) Apoptosis
and apoptosis-related proteins (Fas, Fas ligand, bcl-2, p53)
in macrophages of human ovarian epithelial tumors .European
Journal of Gynecology and Oncology. 21(2):141-5. |
|
Bechmann,
I., Lossau, S., Steiner, B., Mor, G., Gimsa, U., Nitsch, R.
(2000) Reactive Astrocytes upregulate Fas (CD 95) and Fas Ligand
(CD 95L) expression but do not undergo cell death in the course
of anterograde degeneration. Glia. 27:62-74 (Full Text) |
|
Nilsen,
J., Mor, G., Naftolin, F. (2000) Estrogen -regulated developmental
neuronal apoptosis is determined by estrogen receptor subtype
and the Fas/Fas ligand system. Journal of Neurobiology. 43:
64-78 (Full Text) |
|
Yue,
W., Mor, G., Naftolin, F., Pauley, R., Shim, WS., Harvey, HA.,
Santen, RJ. (2000) Use of aromatase inhibitors in breast carcinoma.
Endocrine Management of Breast Cancer |
|
Jefcoate
CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner
SJ, Tekmal R, Demers L, Pauley R,Naftolin F, Mor G, Berstein
L (2000) Tissue-specific synthesis and oxidative . J Natl Cancer
Inst Monogr. 27: 95-112. |
|
Rutherford,
T., Brown, WD., Sapi, E., Aschkenazi, S., Moñoz, A., Mor, G.
(2000) Loss of estrogen receptor-b expression in metastatic
ovarian cancer. Obstetrics & Gynecology. 96:417-421 |
|
Song,
J., Sapi, E., Brown, WD., Nilsen, J., Naftolin, F., Mor, G.
(2000) Mammary Gland Remodeling: Expression and Role of the
Fas/Fas Ligand System during Pregnancy, Lactation and Involution.
Journal of Clinical Investigation. Editorial |
|
Sapi
E, Brown W., Aschkenazy S, Tartaro K., Lim C., Munoz A.,. Kacinski
B M., Rutherford T, Mor G. (2000) Regulation of Fas Ligand expression
by estrogen in normal ovary. International Journal of Cancer.
Submitted |
|
Silva,
I. Mor, G. Naftolin, F. (2000) Estrogen and the aging brain.
Maturitas: in press |
|
Gil
Mor, Amanda Muñoz, Rich Redlinger jr., Ivaldo Silva, Joon Song
and Fortune Kohen (2000) The role of the Fas/Fas ligand system
in the estrogen-induced thymic alteration American Journal of
Reproductive Immunology. Submitted |
|
Mor,
G. Eliza, M (2000) Plasmid DNA vaccines: immunology, tolerance
and autoimmunity. Molecular Biotechnology. In press |
|
Last
Modified: July 10, 2002 (KP)
©Copyright
2004, Yale University School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences. All rights reserved.
Comments or suggestions to the Site
Editor
Home URL: http://info.med.yale.edu/obgyn |
